Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals Inc. (AGNPF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AGNPF · as of Jun 15, 2026
Key Statistics
Explore Algernon Pharmaceuticals Inc. Data
agnpf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
agnpf competitorsAGNPF
AAGH
ADXS
APLIF
HESG
IBOGFStock Performance
Full HistoryAbout Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals Inc. is a biopharmaceutical firm actively engaged in drug development at the clinical trial stage. Its therapeutic endeavors span a range of challenging medical conditions, in…
what is algernon pharmaceuticals inc. · agnpf stock overview · algernon pharmaceuticals inc. company profile · who is algernon pharmaceuticals inc. ceo · agnpf OTC · algernon pharmaceuticals inc. headquarters · algernon pharmaceuticals inc. business segments
About Stock Overview & Key Data
Algernon Pharmaceuticals Inc. (AGNPF) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 11, 2016. As of the latest trading session, AGNPF stock price is $0.43, with a market capitalization of $1.5M. The stock has returned -37.03% over the past 12 months and -13.10% year-to-date.
In fiscal year 2025, Algernon Pharmaceuticals Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Algernon Pharmaceuticals Inc. (AGNPF) stock price is $0.43. The stock is traded on OTC under the ticker symbol AGNPF. The 52-week range is $0.23 – $0.71.